Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma

Molecular Cancer Research

Volumn 11, Issue 12, 2013, Pages 1611-1623

  Westhoff, Mike Andrew ^a   Zhou, Shaoxia ^a   Nonnenmacher, Lisa ^a   Karpel Massler, Georg ^a,b   Jennewein, Claudia ^a   Schneider, Matthias ^a,b   Halatsch, Marc Eric ^b   Carragher, Neil O ^d   Baumann, Bernd ^a   Krause, Alexander ^c   Simmet, Thomas ^a   Bachem, Max G ^a   Wirtz, Christian R ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c AHF Analysentechnik AG   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR ABLATION; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISULFIRAM; ENZYME INHIBITORS; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; METALLOPROTEASES; MICE; NEOPLASM INVASIVENESS; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84891348985     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0435-T     Document Type: Article

References (49)

1. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 2010;10:319-31.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
3. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492-507.
4. Giese A. Glioma invasion-pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1. Acta Neurochir Suppl 2003;88:153-62.
5. Idbaih A, Marie Y, Sanson M. NFKBIA deletion in glioblastomas.NEngl J Med 2011;365:277-278.
6. Karl S, Pritschow Y, Volcic M, Hacker S, Baumann B, Wiesmuller L, et al. Identification of a novel pro-apoptotic function of NF-kappaB in the DNA damage response. J Cell Mol Med 2009;13:4239-56.
7. Jennewein C, Karl S, Baumann B, Micheau O, Debatin KM, Fulda S. Identification of a novel pro-apoptotic role of NF-kappaB in the regulation of TRAIL-and CD95-mediated apoptosis of glioblastoma cells. Oncogene 2011;31:1468-74.
8. La Ferla-Bruhl K, Westhoff MA, Karl S, Kasperczyk H, Zwacka RM, Debatin KM, et al. NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene 2007;26:571-82.
9. Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-kappaB induced invasion by gliomas. J Neurooncol 2010;101:227-35.
10. Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, Klopfenstein JD, et al. MMP-2siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS ONE 2011;6:e20614.
11. Westhoff MA, Zhou S, Bachem MG, Debatin KM, Fulda S. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene 2008;27:5169-81.
12. Syrovets T, Gschwend JE, Buchele B, Laumonnier Y, Zugmaier W, Genze F, et al. Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J Biol Chem 2005;280:6170-80.
13. Wei J, Zhou S, Bachem MG, Debatin KM, Beltinger C. Infiltration of blood outgrowth endothelial cells into tumor spheroids: role of matrix metalloproteinases and irradiation. Anticancer Res 2007; 27:1415-21.
14. Fulda S, Wick W, Weller M, Debatin KM. Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 2002; 8:808-15.
15. Cimpean AM, Ribatti D, Raica M. The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis 2008;11:311-9.
16. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6:56-68.
17. Lee BH, Park SY, Kang KB, Park RW, Kim IS. NF-kappaB activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun 2002;297:1218-24.
18. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50: 556-65.
19. Fukuyama R, Ng KP, Cicek M, Kelleher C, Niculaita R, Casey G, et al. Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Mol Carcinog 2007;46:402-13.
20. Lin ML, Lu YC, Chung JG, Wang SG, Lin HT, Kang SE, et al. Downregulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog 2010;49:783-97.
21. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci 2003;8:e261-9.
22. Annabi B, Laflamme C, Sina A, Lachambre MP, Beliveau R. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation 2009;6:8.
23. Wisniewski P, Ellert-Miklaszewska A, Kwiatkowska A, Kaminska B. Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFkappaB-TIMP-2 pathway. Cell Signal 2010;22:212-20.
24. Stewart CE, Sayers I. Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells. BMC Mol Biol 2009;10:75.
25. Wang Y. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med Res Rev 2001;21:146-70.
26. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J 1997;16:2319-32.
27. Raghu H, Gondi CS, Dinh DH, Gujrati M, Rao JS. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch-1 receptor. Mol Cancer 2011;10:130.
28. Jacobsen E, Martensen-Larsen O. Treatment of alcoholism with tetraethylthiuram disulfide (antabuse). J Am Med Assoc 1949;139: 918-22.
29. Martensen-Larsen O. Treatment of alcoholism with a sensitizing drug. Lancet 1948;2:1004.
30. Richert DA, Vanderlinde R, WesterfeldWW.The composition of rat liver xanthine oxidase and its inhibition by antabuse. J Biol Chem 1950; 186:261-74.
31. Kast RE, Belda-Iniesta C. Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis. Curr Stem Cell Res Ther 2009;4:314-7.
32. Guo X, Xu B, Pandey S, Goessl E, Brown J, Armesilla AL, et al. Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett 2010;290:104-13.
33. Wang W, McLeod HL, Cassidy J. Disulfiram-mediated inhibition of NFkappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer 2003;104:504-11.
34. Cho HJ, Lee TS, Park JB, Park KK, Choe JY, Sin DI, et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 2007;40: 1069-76.
35. Shian SG, Kao YR, Wu FY, Wu CW. Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram. Mol Pharmacol 2003;64: 1076-84.
36. De Witt Hamer PC, Van Tilborg AA, Eijk PP, Sminia P, Troost D, Van Noorden CJ, et al. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 2008;27:2091-6.
37. Jones TR, Ruoslahti E, Schold SC, Bigner DD. Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res 1982, 42:168-77.
38. Chang HJ, Kim MH, Baek MK, Park JS, Chung IJ, Shin BA, et al. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Anticancer Res 2007;27:3411-7.
39. Wang Y, Dang J, Wang H, Allgayer H, Murrell GA, Boyd D. Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem 2000;267:3248-54.
40. Moreau M, Mourah S, Dosquet C. Beta-Catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells. Int J Cancer 2011;128:1280-92.
41. Faralli JA, Schwinn MK, Gonzalez JM Jr, Filla MS, Peters DM. Functional properties of fibronectin in the trabecular meshwork. Exp Eye Res 2009;88:689-93.
42. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003;116:3269-76.
43. Colin C, Baeza N, Bartoli C, Fina F, Eudes N, Nanni I, et al. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Oncogene 2006;25:2818-26.
44. TrialX Web Site. [updated 2013 Jul 22; cited 2013 Feb]. Available from: http://trialx.com/curetalk/2012/12/disulfiram-anti-alcoholism-drugsbrain-cancer- study-gets-2-5-m-grant/ [accessed Feb 27, 2013].
45. Dellatore SM, Garcia AS, Miller WM. Mimicking stem cell niches to increase stemcell expansion. Curr Opin Biotechnol 2008;19:534-40.
46. Westhoff MA, Fulda S. Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updat 2009;12:127-36.
47. Oliveira R, Christov C, Guillamo JS, de Bouard S, Palfi S, Venance L, et al. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol 2005;6:7.
48. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 2004;1:165-76.
49. Brockschmidt A, Trost D, Peterziel H, Zimmermann K, Ehrler M, Grassmann H, et al. KIAA1797/FOCADencodes a novel focal adhesion protein with tumour suppressor function in gliomas. Brain 2012;135: 1027-41.